Therefore, in this study, we aimed to clarify the anti-tumor effect of an ATR inhibitor or an ATM inhibitor combined with DXR, CDDP, or irradiation, and if the combination of the ATR inhibitor and the Chk1 inhibitor could induce DNA damage in endometrial cancer cells. The gene discussed is ATM; the disease is endometrial cancer.